Jilin Aodong Pharmaceutical Group Co Ltd

SHE:000623 China Drug Manufacturers - Specialty & Generic
Market Cap
$3.04 Billion
CN¥22.32 Billion CNY
Market Cap Rank
#4895 Global
#562 in China
Share Price
CN¥18.66
Change (1 day)
+0.65%
52-Week Range
CN¥15.16 - CN¥21.82
All Time High
CN¥24.39
About

Jilin Aodong Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China. The company provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in … Read more

Jilin Aodong Pharmaceutical Group Co Ltd (000623) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.004x

Based on the latest financial reports, Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a cash flow conversion efficiency ratio of 0.004x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥112.12 Million) by net assets (CN¥30.82 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Jilin Aodong Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Jilin Aodong Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Jilin Aodong Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jilin Aodong Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Jilin Aodong Pharmaceutical Group Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Jilin Aodong Pharmaceutical Group Co Ltd from 1998 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥29.28 Billion CN¥59.48 Million 0.002x -17.92%
2023-12-31 CN¥27.50 Billion CN¥68.06 Million 0.002x -84.62%
2022-12-31 CN¥26.34 Billion CN¥423.86 Million 0.016x +24.03%
2021-12-31 CN¥25.04 Billion CN¥324.85 Million 0.013x -21.81%
2020-12-31 CN¥23.53 Billion CN¥390.41 Million 0.017x -1.86%
2019-12-31 CN¥22.44 Billion CN¥379.46 Million 0.017x +3.32%
2018-12-31 CN¥21.24 Billion CN¥347.64 Million 0.016x +31.02%
2017-12-31 CN¥20.54 Billion CN¥256.49 Million 0.012x -29.39%
2016-12-31 CN¥18.87 Billion CN¥333.81 Million 0.018x -19.85%
2015-12-31 CN¥17.58 Billion CN¥388.03 Million 0.022x -3.28%
2014-12-31 CN¥12.66 Billion CN¥288.83 Million 0.023x +20.82%
2013-12-31 CN¥10.66 Billion CN¥201.22 Million 0.019x -32.39%
2012-12-31 CN¥9.75 Billion CN¥272.40 Million 0.028x +134.54%
2011-12-31 CN¥9.09 Billion CN¥108.30 Million 0.012x -50.47%
2010-12-31 CN¥7.25 Billion CN¥174.22 Million 0.024x -25.95%
2009-12-31 CN¥6.56 Billion CN¥213.03 Million 0.032x -28.95%
2008-12-31 CN¥5.14 Billion CN¥235.03 Million 0.046x -41.87%
2007-12-31 CN¥4.89 Billion CN¥384.69 Million 0.079x -13.70%
2006-12-31 CN¥2.06 Billion CN¥187.99 Million 0.091x +13.05%
2005-12-31 CN¥1.69 Billion CN¥136.26 Million 0.081x -39.83%
2004-12-31 CN¥1.63 Billion CN¥218.53 Million 0.134x +22.53%
2003-12-31 CN¥1.35 Billion CN¥147.65 Million 0.109x +3025.54%
2002-12-31 CN¥1.22 Billion CN¥-4.58 Million -0.004x -103.18%
2001-12-31 CN¥1.18 Billion CN¥138.76 Million 0.117x +68.73%
2000-12-31 CN¥1.11 Billion CN¥77.04 Million 0.070x -54.52%
1999-12-31 CN¥720.42 Million CN¥110.18 Million 0.153x +414.76%
1998-12-31 CN¥635.85 Million CN¥-30.90 Million -0.049x --